LAMA2 Gene Muscular Dystrophy Type 1A Genetic Test
Test Name: LAMA2 Gene Muscular Dystrophy Type 1A Genetic Test
Components: DNA sample (Blood or Extracted DNA or One drop Blood on FTA Card)
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for LAMA2 Gene Muscular Dystrophy Type 1A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LAMA2 Gene Muscular Dystrophy Type 1A
What is LAMA2 Gene Muscular Dystrophy Type 1A?
The LAMA2 gene is associated with a specific type of muscular dystrophy called Muscular Dystrophy Type 1A (MDC1A). This type of muscular dystrophy is caused by mutations in the LAMA2 gene, which is responsible for producing a protein called laminin alpha-2. This protein is important for maintaining the structure and function of muscle cells.
About the Genetic Test
NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous sequencing of multiple genes or even the entire genome. In the case of MDC1A, NGS can be used to analyze the LAMA2 gene for any mutations or variations that may be causing the disease.
The LAMA2 gene NGS genetic test involves obtaining a DNA sample, typically through a blood sample, from the individual suspected of having MDC1A. The DNA is then sequenced using NGS technology to identify any mutations or variations in the LAMA2 gene. The results of the test can help confirm a diagnosis of MDC1A and provide information about the specific mutation(s) present in the gene.
Who Should Get Tested?
This genetic test can be useful for individuals with symptoms suggestive of MDC1A, such as muscle weakness, difficulty walking, and delayed motor development. It can also be used for carrier testing in individuals with a family history of MDC1A or for prenatal testing in families with a known LAMA2 gene mutation.
It is important to note that genetic testing for MDC1A should be conducted and interpreted by a qualified healthcare professional or genetic counselor. They can provide guidance on the appropriateness of testing, help interpret the results, and provide information about the implications of the test results for the individual and their family.
Test Name | LAMA2 Gene Muscular dystrophy type 1A Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for LAMA2 Gene Muscular dystrophy type 1A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with LAMA2 Gene Muscular dystrophy type 1A |
Test Details |
The LAMA2 gene is associated with a specific type of muscular dystrophy called Muscular Dystrophy Type 1A (MDC1A). This type of muscular dystrophy is caused by mutations in the LAMA2 gene, which is responsible for producing a protein called laminin alpha-2. This protein is important for maintaining the structure and function of muscle cells. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the simultaneous sequencing of multiple genes or even the entire genome. In the case of MDC1A, NGS can be used to analyze the LAMA2 gene for any mutations or variations that may be causing the disease. The LAMA2 gene NGS genetic test involves obtaining a DNA sample, typically through a blood sample, from the individual suspected of having MDC1A. The DNA is then sequenced using NGS technology to identify any mutations or variations in the LAMA2 gene. The results of the test can help confirm a diagnosis of MDC1A and provide information about the specific mutation(s) present in the gene. This genetic test can be useful for individuals with symptoms suggestive of MDC1A, such as muscle weakness, difficulty walking, and delayed motor development. It can also be used for carrier testing in individuals with a family history of MDC1A or for prenatal testing in families with a known LAMA2 gene mutation. It is important to note that genetic testing for MDC1A should be conducted and interpreted by a qualified healthcare professional or genetic counselor. They can provide guidance on the appropriateness of testing, help interpret the results, and provide information about the implications of the test results for the individual and their family. |